SEC 13F Intelligence

Burrage Capital Management LLC / PLX

Burrage Capital Management LLC’s Protalix Biotherapeutics Inc Position

Does Burrage Capital Management LLC own Protalix Biotherapeutics Inc (PLX)? Not currently — the last reported position was 2.13M shares worth $9M in Q1 2021; the fund’s latest 13F (Q3 2021) no longer reports it.

Position Value
$9M
Q1 2021
Shares
2.13M
% of Portfolio
+7.68%
Quarters Held
2
position exited

Position History PLX

Reported value by quarter
Q4 ’20: $9MQ4 ’20Q1 ’21: $9MQ1 ’21filingsflow.com
QuarterSharesValue% of Portfolio
Q1 20212.13M$9M+7.68%
Q4 20202.47M$9M+6.83%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Burrage Capital Management LLC’s full portfolio or all institutional holders of PLX.